Teva- Pharmaceutical Industries Ltd. ADR (TEVA) currently has a stock price of $9.45. The stock saw a sharp increase in the last trading session, hitting a high of $9.48 after opening at $9.06. The lowest recorded price for the day was $9.04 before it closed at $9.05.
In terms of market performance, Teva- Pharmaceutical Industries Ltd. ADR had a somewhat regular. The highest value for the stock in the past year was $11.44 on 01/12/23, while the lowest value was $7.09 on 05/31/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of TEVA Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Teva- Pharmaceutical Industries Ltd. ADR’s current trading price is -17.43% away from its 52-week high, while its distance from the 52-week low is 33.38%. The stock’s price range during this period has fluctuated between $7.09 and $11.44. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 9.63 million for the day, which was evidently higher than the average daily volume of 8.31 million over the last three months.
Financial Performance and Market Capitalization
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has experienced a quarterly decline of -3.08% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 10.59B and boasts a workforce of 36826 employees.
Analysts’ Ratings For Teva- Pharmaceutical Industries Ltd. ADR
As of right now, 3 analysts are rating Teva- Pharmaceutical Industries Ltd. ADR as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 2 analysts are rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.12, with a change in price of +1.88. Similarly, Teva- Pharmaceutical Industries Ltd. ADR recorded 9,186,249 in trading volume during the last 100 days, posting a change of +24.83%.
TEVA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TEVA stands at 2.93. Similarly, the long-term debt-to-equity ratio is also 2.72.
TEVA Stock Stochastic Average
The raw stochastic average for Teva- Pharmaceutical Industries Ltd. ADR over the last 50 days is presently at 52.35%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 92.03%. Further, the company’s Stochastic %K and %D values for the last 20 days were 68.09% and 59.89%, respectively.
TEVA Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 3.62%.However, over the last six months, we can see a weaker performance of 18.87%. Over the last 30 days, the price of TEVA has fallen by 16.38%. And in the last five days, it has surged by 7.14%.
